Sponsored
Sponsored
Media Summary: Active Surveillance Patients International (ASPI) hosts guest speakers Professor Freddie Hamdy (University of Oxford) and ... Gerald L. Andriole, MD, who served on the cause of death ascertainment committee for the In this ASPI educational session, Prof. Freddie Hamdy (University of Oxford) and Prof. Jenny Donovan (University of Bristol) ...

The Protect Trial Prostate Testing - Detailed Analysis & Overview

Active Surveillance Patients International (ASPI) hosts guest speakers Professor Freddie Hamdy (University of Oxford) and ... Gerald L. Andriole, MD, who served on the cause of death ascertainment committee for the In this ASPI educational session, Prof. Freddie Hamdy (University of Oxford) and Prof. Jenny Donovan (University of Bristol) ... Active monitoring, radical prostatectomy or radiotherapy? For men with clinically localized Patients with Gleason 3+4=7 represent one of the largest "grey areas" in the world of Piet Dirix, MD, PhD, Iridium Network, Antwerp, Belgium, discusses the limited role of androgen deprivation therapy (ADT) in ...

Learn more about Dr. Matthew Cooperberg here: To learn more about Donate to PCRI: For more information, visit 1:11 What are some of the newest developments ... Malcom Mason, MD, Cancer Research Wales Professor of Clinical Oncology at Cardiff University, discusses the significance of ... I hope this helps and good luck with your journey! ▶️ live event: Christopher J. Kane, MD, MS, FACS, Professor of Urology, University of California, San Diego, San Diego, California, presents an ...

Photo Gallery

The Protect Trial: Prostate Testing for Cancer and Treatment
Doctor Explains the ProtecT Trial
Update on Prostatectomy Versus Observation Trials
What the ProtecT Trial Means: 15-Year Results for Active Surveillance and Prostate Cancer Treatments
ProtecT trial: a battle between three treatments for patients with localized prostate cancer
3+4=7 #ProstateCancer  | Active Surveillance vs. Focal Therapy | #MarkScholzMD #AlexScholz #PCRI
Risk Assessment of PSA Recurrent Prostate Cancer
Reducing ADT use in low-PSA prostate cancer: insights from SAFE trial
Addressing the issues faced in the ProtecT trial for patients with localized prostate cancer
Active Surveillance, Genetic Testing & More | Matthew Cooperberg, MD & Q+A with Mark Moyad, MD #PCRI
Prostate Cancer Clinical Trial: The INNOVATE Trial (NRG-GU008)
PROMs in the ProtecT trial of PCa treatments
View Detailed Profile
The Protect Trial: Prostate Testing for Cancer and Treatment

The Protect Trial: Prostate Testing for Cancer and Treatment

Active Surveillance Patients International (ASPI) hosts guest speakers Professor Freddie Hamdy (University of Oxford) and ...

Doctor Explains the ProtecT Trial

Doctor Explains the ProtecT Trial

For more info, visit: https://www.primrmed.com/cancer/

Sponsored
Update on Prostatectomy Versus Observation Trials

Update on Prostatectomy Versus Observation Trials

Gerald L. Andriole, MD, who served on the cause of death ascertainment committee for the

What the ProtecT Trial Means: 15-Year Results for Active Surveillance and Prostate Cancer Treatments

What the ProtecT Trial Means: 15-Year Results for Active Surveillance and Prostate Cancer Treatments

In this ASPI educational session, Prof. Freddie Hamdy (University of Oxford) and Prof. Jenny Donovan (University of Bristol) ...

ProtecT trial: a battle between three treatments for patients with localized prostate cancer

ProtecT trial: a battle between three treatments for patients with localized prostate cancer

Active monitoring, radical prostatectomy or radiotherapy? For men with clinically localized

Sponsored
3+4=7 #ProstateCancer  | Active Surveillance vs. Focal Therapy | #MarkScholzMD #AlexScholz #PCRI

3+4=7 #ProstateCancer | Active Surveillance vs. Focal Therapy | #MarkScholzMD #AlexScholz #PCRI

Patients with Gleason 3+4=7 represent one of the largest "grey areas" in the world of

Risk Assessment of PSA Recurrent Prostate Cancer

Risk Assessment of PSA Recurrent Prostate Cancer

As part of the 2024

Reducing ADT use in low-PSA prostate cancer: insights from SAFE trial

Reducing ADT use in low-PSA prostate cancer: insights from SAFE trial

Piet Dirix, MD, PhD, Iridium Network, Antwerp, Belgium, discusses the limited role of androgen deprivation therapy (ADT) in ...

Addressing the issues faced in the ProtecT trial for patients with localized prostate cancer

Addressing the issues faced in the ProtecT trial for patients with localized prostate cancer

The ProtecT trial

Active Surveillance, Genetic Testing & More | Matthew Cooperberg, MD & Q+A with Mark Moyad, MD #PCRI

Active Surveillance, Genetic Testing & More | Matthew Cooperberg, MD & Q+A with Mark Moyad, MD #PCRI

Learn more about Dr. Matthew Cooperberg here: https://urology.ucsf.edu/people/cooperberg To learn more about

Prostate Cancer Clinical Trial: The INNOVATE Trial (NRG-GU008)

Prostate Cancer Clinical Trial: The INNOVATE Trial (NRG-GU008)

For more info, visit: https://www.primrmed.com/cancer-clinical-

PROMs in the ProtecT trial of PCa treatments

PROMs in the ProtecT trial of PCa treatments

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bju.13582/abstract PROMs in

Testing and Monitoring #ProstateCancer | #MarkScholzMD #AlexScholz #PCRI

Testing and Monitoring #ProstateCancer | #MarkScholzMD #AlexScholz #PCRI

Donate to PCRI: https://pcri.org/donate/ For more information, visit https://pcri.org 1:11 What are some of the newest developments ...

What Men Should Know About AI, PSA, Prostate Cancer & Diagnosis with Dr. Jennifer Miles Thomas – 182

What Men Should Know About AI, PSA, Prostate Cancer & Diagnosis with Dr. Jennifer Miles Thomas – 182

Can AI help you understand your

Dr. Mason Discusses the PROTECT Study in Localized Prostate Cancer

Dr. Mason Discusses the PROTECT Study in Localized Prostate Cancer

Malcom Mason, MD, Cancer Research Wales Professor of Clinical Oncology at Cardiff University, discusses the significance of ...

This Prostate Cancer Test Has 95% Accuracy - Here's Why

This Prostate Cancer Test Has 95% Accuracy - Here's Why

I hope this helps and good luck with your journey! ▶️ live event: https://www.youtube.com/live/DtaciS_OWXs?feature=share ...

Gleason 4 & Cribriform #ProstateCancer | PROTECT Trial Data | #MarkScholzMD #AlexScholz #PCRI

Gleason 4 & Cribriform #ProstateCancer | PROTECT Trial Data | #MarkScholzMD #AlexScholz #PCRI

JAMA Article: https://jamanetwork.com/journals/jamaoncology/article-abstract/2840006 Donate to PCRI: https://pcri.org/donate/ For ...

Treatment of Prostate Cancer: Active Surveillance 2025 Update and the PIVOT Trial

Treatment of Prostate Cancer: Active Surveillance 2025 Update and the PIVOT Trial

Christopher J. Kane, MD, MS, FACS, Professor of Urology, University of California, San Diego, San Diego, California, presents an ...

Understanding the Value of PSA Testing for Prostate Cancer Detection

Understanding the Value of PSA Testing for Prostate Cancer Detection

Stanford urology experts explain what

Localized Prostate Cancer and Management

Localized Prostate Cancer and Management

PSA testing

Related Video Content

PROTECT Definition & Meaning - Merriam-Webster information

May 24, 2026 · The meaning of PROTECT is to cover or shield from exposure, injury, damage, or destruction : guard....

PROTECT | English meaning - Cambridge Dictionary information

PROTECT definition: 1. to keep someone or something safe from injury, damage, or loss: 2. If a government protects...

PROTECT Definition & Meaning | Dictionary.com information

PROTECT definition: to defend or guard from attack, invasion, loss, annoyance, insult, etc.; cover or shield from...

What does PROTECT mean? - Definitions.net information

Definition of PROTECT in the Definitions.net dictionary. Meaning of PROTECT. What does PROTECT mean? Information and...

PROTECT Synonyms & Antonyms - 102 words | Thesaurus.com information

Find 102 different ways to say PROTECT, along with antonyms, related words, and example sentences at Thesaurus.com.

Sponsored